Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Clinical trial NCT06117878 · UNKNOWN
Trial details
- NCT number
- NCT06117878
- Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.